tetradecanoylphorbol acetate and Bone Loss, Perimenopausal

tetradecanoylphorbol acetate has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ershler, WB; Keller, ET; Stebler, BS; Sun, WH	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Bone Loss, Perimenopausal

Article	Year
Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochemical and biophysical research communications, 1998, Mar-27, Volume: 244, Issue:3 Topics: DNA-Binding Proteins; Drug Interactions; Estradiol; Female; HeLa Cells; Humans; I-kappa B Proteins; Interleukin-6; NF-kappa B; NF-KappaB Inhibitor alpha; Osteoporosis, Postmenopausal; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription, Genetic; Up-Regulation	1998

Article

Year

Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation.

Biochemical and biophysical research communications, 1998, Mar-27, Volume: 244, Issue:3

Topics: DNA-Binding Proteins; Drug Interactions; Estradiol; Female; HeLa Cells; Humans; I-kappa B Proteins; Interleukin-6; NF-kappa B; NF-KappaB Inhibitor alpha; Osteoporosis, Postmenopausal; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription, Genetic; Up-Regulation

1998